JohnALewisMDMedical Director Faulkner Community Phys

PubMed

• 17 citations
  Evaluation of 3D fluoroscopic image generation from a single planar treatment image on patient data with a modified XCAT phantom
  Pankaj Mishra, Ruijiang Li, Sara St. James, Raymond H. Mak, Christopher L. Williams, Y Yue, Ross Berbeco, John Austin Lewis> ;Physics in Medicine and Biology. 2013 Feb 21
• 51 citations
  Development of a purification process for adenovirus: controlling virus aggregation to improve the clearance of host cell DNA.
  John O. Konz, Ann L. Lee, John A. Lewis, Sangeetha L. Sagar> ;Biotechnology Progress. 2008 Sep 5
• 2 citations
  Quantifying the titer and quality of adenovirus stocks.
  Fubao Wang, Bill C. Mathis, Allison G. Montalvo, Jayanthi J. Wolf, John A. Lewis> ;Methods in Molecular Biology. 2008 Jan 1
• 38 citations
  Development and application of a quantitative RT-PCR potency assay for a pentavalent rotavirus vaccine (RotaTeq).
  Todd Ranheim, Pamela K. Mathis, Daniel B. Joelsson, Mary Ellen Smith, Kathryn M. Campbell, Gwendolyn Lucas, Scott L. Barmat, Erin Melissen, Robert Benz, John A. Lewis,...> ;Journal of Virological Methods. 2006 Feb 1
• 31 citations
  Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and...
  Fubao Wang, Alan C. Puddy, Bill C. Mathis, Allison G. Montalvo, Anthonise A. Louis, Jennifer L. McMackin, Jenny Xu, Yuhua Zhang, Charles Y. Tan, Timothy L. Schofield, ...> ;Vaccine. 2005 Aug 22
• 16 citations
  Investigation of the role of uncharged trna in the regulation of polypeptide chain initiation by amino acid starvation in cultured mammalian cells; a reappraisal.
  Sara A. Austin, Virginia M. Pain, John A. Lewis, Micshael J. Clemens> ;European Journal of Biochemistry. 2005 Mar 3
• 2 citations
  Evaluation of the purity of a purified, inactivated hepatitis A vaccine (VAQTA).
  John P. Hennessey, C. B. Oswald, Dong Z, John A. Lewis, Robert D. Sitrin> ;Vaccine. 1999 Jul 16
• 33 citations
  Immunoprecipitation and Virus Neutralization Assays Demonstrate Qualitative Differences between Protective Antibody Responses to Inactivated Hepatitis A Vaccine and Pa...
  Stanley M. Lemon, Paula C. Murphy, Philip J. Provost, Ira Chalikonda, Joseph P. Davide, Timothy L. Schofield, David R. Nalin, John A. Lewis> ;The Journal of Infectious Diseases. 1997 Jul 1
• 149 citations
  Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.
  Joanne E. Tomassini, Harold G. Selnick, M E Davies, M. E. Armstrong, J. Baldwin, M Bourgeois, J C Hastings, Daria J. Hazuda, John A. Lewis, Mcclements William L> ;Antimicrobial Agents and Chemotherapy. 1994 Dec 1
• 13 citations
  Anatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trial
  Alan Werzberger, Barbara J. Kuter, Daniel Shouval, Barbara Mensch, Leora Brown, Brian L. Wiens, John A. Lewis, William J. Miller, Robert D. Sitrin, Philip J. Provost, ...> ;Journal of Hepatology. 1993 Jan 1
• 39 citations
  Development of the formalin-inactivated hepatitis A vaccine, VAQTATM from the live attenuated virus strain CR326F
  M. E. Armstrong, Paula A. Giesa, Joseph P. Davide, Francine Redner, Julie A. Waterbury, Audrey E. Rhoad, Robert D. Keys, Philip J. Provost, John A. Lewis> ;Journal of Hepatology. 1993 Jan 1
• 15 citations
  Inactivated hepatitis A vaccine in childhood: implications for disease control
  David R. Nalin, Leora Brown, Barbara J. Kuter, C M Patterson, B. McGuire, Alan Werzberger, M. Santosham, Stan L. Block, Keith S. Reisinger, Barbara Watson, Stuart E. S...> ;Vaccine. 1993 Jan 1
• 53 citations
  Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations : an overview
  David R. Nalin, Barbara J. Kuter, Leora Brown, Carol Patterson, Gary B. Calandra, Alan Werzberger, Daniel Shouval, Edward F. Ellerbeck, Stanley L. Block, Robert Bishop...> ;Journal of Hepatology. 1993 Jan 1
• 56 citations
  Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis.
  Daniel Shouval, Yaffa Ashur, Ruth Adler, John A. Lewis, Marcy E. Armstrong, Joseph P. Davide, B. McGuire, Barbara J. Kuter, L. Brown, William J. Miller, Y. Elkana, Dav...> ;Vaccine. 1993 Jan 1
• 20 citations
  Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: effects of single and booster injections, and comparison to administration of immune gl...
  Daniel Shouval, Yaffa Ashur, Ruth Adler, John A. Lewis, William J. Miller, Barbara J. Kuter, Leora Brown, David R. Nalin> ;Journal of Hepatology. 1993 Jan 1
• 11 citations
  Evaluation of a microcarrier process for large-scale cultivation of attenuated hepatitis A.
  Beth Junker, Florence J. Wu, S. Wang, J. Waterbury, G. Hunt, John P. Hennessey, John G. Aunins, John A. Lewis, Melvin Silberklang, Barry C. Buckland> ;Cytotechnology. 1992 Jan 1
• 20 citations
  Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A.
  Edward F. Ellerbeck, John A. Lewis, David R. Nalin, Kenneth Gershman, William J. Miller, Marcy E. Armstrong, Joseph P. Davide, Audrey E. Rhoad, Brenda McGuire, Gary B....> ;Vaccine. 1992 Jan 1
• 10 citations
  Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarifications.
  Gregory Larosa, Joseph P. Davide, Kent J. Weinhold, Waterbury Julie Ann, Albert T. Profy, John A. Lewis, Alphonse J. Langlois, Gordon R. Dreesman, R N Boswell, Phillip...> ;Science. 1991 Feb 15
• 12 citations
  Yeast-expressed p55 precursor core protein of human immunodeficiency virus type 1 does not elicit protective immunity in chimpanzees.
  Emilio A. Emini, William A. Schleif, Quintero Julio C, Patricia Conard, Jorg W. Eichberg, George P. Vlasuk, E. Dale Lehman, Polokoff Mark A, Ted F. Schaeffer, Schultz ...> ;AIDS Research and Human Retroviruses. 1990 Nov 1
• 546 citations
  Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.
  Gregory Larosa, Joseph P. Davide, Kent J. Weinhold, Waterbury Julie Ann, Albert T. Profy, John A. Lewis, Alphonse J. Langlois, Gordon R. Dreesman, R N Boswell, Phillip...> ;Science. 1990 Aug 24
• 132 citations
  Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees.
  Emilio A. Emini, Peter L. Nara, William A. Schleif, John A. Lewis, Joseph P. Davide, D R Lee, J Kessler, S Conley, S Matsushita, S D Putney> ;Journal of Virology. 1990 Aug 1
• 37 citations
  A microtiter cell-culture assay for the determination of anti-human immunodeficiency virus neutralizing antibody activity.
  George A. Robertson, Beverly M. Kostek, William A. Schleif, John A. Lewis, Emilio A. Emini> ;Journal of Virological Methods. 1988 Jul 1
• 34 citations
  Dual Action of Double‐Stranded RNA in Inhibiting Protein Synthesis in Extracts of Interferon‐Treated Mouse L Cells
  John A. Lewis, Ernesto Falcoff, Rebecca Falcoff> ;European Journal of Biochemistry. 1978 May 1
• Join now to see all